{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T03:03:53Z","timestamp":1781665433543,"version":"3.54.5"},"reference-count":41,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,10,7]],"date-time":"2016-10-07T00:00:00Z","timestamp":1475798400000},"content-version":"vor","delay-in-days":494,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1038\/mt.2015.14","type":"journal-article","created":{"date-parts":[[2015,1,26]],"date-time":"2015-01-26T12:14:42Z","timestamp":1422274482000},"page":"1123-1130","source":"Crossref","is-referenced-by-count":20,"title":["Phase 1 Trial of Bi-shRNA STMN1 BIV in Refractory Cancer"],"prefix":"10.1016","volume":"23","author":[{"given":"Minal","family":"Barve","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaohui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Padmasini","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher M","family":"Jay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuquan","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia","family":"Bedell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert G","family":"Mennel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gladice","family":"Wallraven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis Charles","family":"Brunicardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil","family":"Senzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Nemunaitis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald D","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/mt.2015.14_bib1","doi-asserted-by":"crossref","first-page":"e29","DOI":"10.1371\/journal.pbio.0050029","article-title":"Discrete states of a protein interaction network govern interphase and mitotic microtubule dynamics","volume":"5","author":"Niethammer","year":"2007","journal-title":"PLoS Biol"},{"key":"10.1038\/mt.2015.14_bib2","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.4161\/cc.4.12.2171","article-title":"Stathmin prevents the transition from a normal to an endomitotic cell cycle during megakaryocytic differentiation","volume":"4","author":"Iancu-Rubin","year":"2005","journal-title":"Cell Cycle"},{"key":"10.1038\/mt.2015.14_bib3","doi-asserted-by":"crossref","first-page":"3333","DOI":"10.1242\/jcs.111.22.3333","article-title":"The stathmin phosphoprotein family: intracellular localization and effects on the microtubule network","volume":"111 (Pt 22)","author":"Gavet","year":"1998","journal-title":"J Cell Sci"},{"key":"10.1038\/mt.2015.14_bib4","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1517\/14728222.2011.620951","article-title":"Stathmin: a protein with many tasks. New biomarker and potential target in cancer","volume":"15","author":"Belletti","year":"2011","journal-title":"Expert Opin Ther Targets"},{"key":"10.1038\/mt.2015.14_bib5","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1038\/sj.cgt.7701057","article-title":"Proof concept for clinical justification of network mapping for personalized cancer therapeutics","volume":"14","author":"Nemunaitis","year":"2007","journal-title":"Cancer Gene Ther"},{"key":"10.1038\/mt.2015.14_bib6","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1038\/sj.onc.1209864","article-title":"Silencing of stathmin induces tumor-suppressor function in breast cancer cell lines harboring mutant p53","volume":"26","author":"Alli","year":"2007","journal-title":"Oncogene"},{"key":"10.1038\/mt.2015.14_bib7","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1002\/1097-0142(20010415)91:8<1494::AID-CNCR1157>3.0.CO;2-7","article-title":"Oncoprotein 18 overexpression increases the sensitivity to vindesine in the human lung carcinoma cells","volume":"91","author":"Nishio","year":"2001","journal-title":"Cancer"},{"key":"10.1038\/mt.2015.14_bib8","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1038\/sj.bjc.6605537","article-title":"Overexpression of stathmin1 in the diffuse type of gastric cancer and its roles in proliferation and migration of gastric cancer cells","volume":"102","author":"Jeon","year":"2010","journal-title":"Br J Cancer"},{"key":"10.1038\/mt.2015.14_bib9","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1007\/s13277-013-1345-3","article-title":"Overexpression of stathmin 1 confers an independent prognostic indicator in nasopharyngeal carcinoma","volume":"35","author":"Hsu","year":"2014","journal-title":"Tumour Biol"},{"key":"10.1038\/mt.2015.14_bib10","doi-asserted-by":"crossref","first-page":"4897","DOI":"10.1021\/pr100712t","article-title":"Stathmin, a new target of PRL-3 identified by proteomic methods, plays a key role in progression and metastasis of colorectal cancer","volume":"9","author":"Zheng","year":"2010","journal-title":"J Proteome Res"},{"key":"10.1038\/mt.2015.14_bib11","doi-asserted-by":"crossref","first-page":"4834","DOI":"10.1073\/pnas.0806514106","article-title":"Integrated genomic profiling of endometrial carcinoma associates aggressive tumors with indicators of PI3 kinase activation","volume":"106","author":"Salvesen","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/mt.2015.14_bib12","doi-asserted-by":"crossref","first-page":"3368","DOI":"10.1158\/1078-0432.CCR-10-2412","article-title":"Stathmin overexpression identifies high-risk patients and lymph node metastasis in endometrial cancer","volume":"17","author":"Trovik","year":"2011","journal-title":"Clin Cancer Res"},{"key":"10.1038\/mt.2015.14_bib13","doi-asserted-by":"crossref","first-page":"3137","DOI":"10.1007\/s13277-013-0882-0","article-title":"Overexpression of stathmin 1 is associated with poor prognosis of patients with gastric cancer","volume":"34","author":"Ke","year":"2013","journal-title":"Tumour Biol"},{"key":"10.1038\/mt.2015.14_bib14","doi-asserted-by":"crossref","first-page":"5054","DOI":"10.1158\/0008-5472.CAN-10-0545","article-title":"FoxM1 mediates resistance to herceptin and paclitaxel","volume":"70","author":"Carr","year":"2010","journal-title":"Cancer Res"},{"key":"10.1038\/mt.2015.14_bib15","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1002\/cncr.24282","article-title":"Stathmin and tubulin expression and survival of ovarian cancer patients receiving platinum treatment with and without paclitaxel","volume":"115","author":"Su","year":"2009","journal-title":"Cancer"},{"key":"10.1038\/mt.2015.14_bib16","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.4161\/cbt.5.11.3272","article-title":"Silencing stathmin gene expression by survivin promoter-driven siRNA vector to reverse malignant phenotype of tumor cells","volume":"5","author":"Zhang","year":"2006","journal-title":"Cancer Biol Ther"},{"issue":"Pt 5","key":"10.1038\/mt.2015.14_bib17","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1242\/jcs.114.5.909","article-title":"Effects of stathmin inhibition on the mitotic spindle","volume":"114","author":"Iancu","year":"2001","journal-title":"J Cell Sci"},{"key":"10.1038\/mt.2015.14_bib18","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/labinvest.2014.124","article-title":"Overexpression of stathmin 1 is a poor prognostic biomarker in non-small cell lung cancer","volume":"95","author":"Nie","year":"2015","journal-title":"Lab Invest"},{"key":"10.1038\/mt.2015.14_bib19","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1186\/1479-5876-11-212","article-title":"Lentiviral-mediated RNA interference targeting stathmin1 gene in human gastric cancer cells inhibits proliferation in vitro and tumor growth in vivo","volume":"11","author":"Akhtar","year":"2013","journal-title":"J Transl Med"},{"key":"10.1038\/mt.2015.14_bib20","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1038\/cgt.2010.35","article-title":"Enhanced target gene knockdown by a bifunctional shRNA: a novel approach of RNA interference","volume":"17","author":"Rao","year":"2010","journal-title":"Cancer Gene Ther"},{"key":"10.1038\/mt.2015.14_bib21","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1089\/dna.2011.1240","article-title":"In vivo safety and antitumor efficacy of bifunctional small hairpin RNAs specific for the human Stathmin 1 oncoprotein","volume":"30","author":"Phadke","year":"2011","journal-title":"DNA Cell Biol"},{"key":"10.1038\/mt.2015.14_bib22","doi-asserted-by":"crossref","first-page":"e40452","DOI":"10.1371\/journal.pone.0040452","article-title":"PDX-1 is a therapeutic target for pancreatic cancer, insulinoma and islet neoplasia using a novel RNA interference platform","volume":"7","author":"Liu","year":"2012","journal-title":"PLoS One"},{"key":"10.1038\/mt.2015.14_bib23","first-page":"243","article-title":"Preclinical assessment of wt GNE gene plasmid for management of hereditary inclusion body myopathy 2 (HIBM2)","volume":"2","author":"Jay","year":"2008","journal-title":"Gene Regul Syst Bio"},{"key":"10.1038\/mt.2015.14_bib24","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/mt.2011.269","article-title":"Phase I trial of \u201cbi-shRNAi(furin)\/GMCSF DNA\/autologous tumor cell\u201d vaccine (FANG) in advanced cancer","volume":"20","author":"Senzer","year":"2012","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2015.14_bib25","first-page":"209","article-title":"Long term follow up: phase I trial of \u201cbi-shRNA furin\/GMCSF DNA\/autologous tumor cell\u201d immunotherapy (FANG\u2122) in advanced cancer","volume":"4","author":"Senzer","year":"2013","journal-title":"J Vaccines Vaccin"},{"key":"10.1038\/mt.2015.14_bib26","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1159\/000360993","article-title":"Summary of bi-shRNA\/GM-CSF augmented autologous tumor cell immunotherapy (FANG\u2122) in advanced cancer of the liver","volume":"87","author":"Nemunaitis","year":"2014","journal-title":"Oncology"},{"key":"10.1038\/mt.2015.14_bib27","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/nbt0797-647","article-title":"Improved DNA: liposome complexes for increased systemic delivery and gene expression","volume":"15","author":"Templeton","year":"1997","journal-title":"Nat Biotechnol"},{"key":"10.1038\/mt.2015.14_bib28","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1006\/mthe.2001.0266","article-title":"Successful treatment of primary and disseminated human lung cancers by systemic delivery of tumor suppressor genes using an improved liposome vector","volume":"3","author":"Ramesh","year":"2001","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2015.14_bib29","doi-asserted-by":"crossref","first-page":"e34833","DOI":"10.1371\/journal.pone.0034833","article-title":"Phase I clinical trial of systemically administered TUSC2(FUS1)-nanoparticles mediating functional gene transfer in humans","volume":"7","author":"Lu","year":"2012","journal-title":"PLoS One"},{"key":"10.1038\/mt.2015.14_bib30","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1038\/nature08956","article-title":"Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles","volume":"464","author":"Davis","year":"2010","journal-title":"Nature"},{"key":"10.1038\/mt.2015.14_bib31","series-title":"Systemic Apoptic Gene Therapy for Pancreatic Cancer: Multi-Dose Toxicity Study of the BikDD Nanoparticle","author":"Barnhart","year":"2010"},{"key":"10.1038\/mt.2015.14_bib32","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1089\/108729001750072119","article-title":"Development of ribozymes that target stathmin, a major regulator of the mitotic spindle","volume":"11","author":"Mistry","year":"2001","journal-title":"Antisense Nucleic Acid Drug Dev"},{"key":"10.1038\/mt.2015.14_bib33","doi-asserted-by":"crossref","first-page":"3248","DOI":"10.1158\/1535-7163.MCT-06-0227","article-title":"Therapeutic interactions between stathmin inhibition and chemotherapeutic agents in prostate cancer","volume":"5","author":"Mistry","year":"2006","journal-title":"Mol Cancer Ther"},{"key":"10.1038\/mt.2015.14_bib34","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1093\/jnci\/djk135","article-title":"The 1p-encoded protein stathmin and resistance of malignant gliomas to nitrosoureas","volume":"99","author":"Ngo","year":"2007","journal-title":"J Natl Cancer Inst"},{"key":"10.1038\/mt.2015.14_bib35","doi-asserted-by":"crossref","first-page":"567","DOI":"10.2119\/2007-00046.Wang","article-title":"Inhibiting proliferation and enhancing chemosensitivity to taxanes in osteosarcoma cells by RNA interference-mediated downregulation of stathmin expression","volume":"13","author":"Wang","year":"2007","journal-title":"Mol Med"},{"key":"10.1038\/mt.2015.14_bib36","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/nature03121","article-title":"Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs","volume":"432","author":"Soutschek","year":"2004","journal-title":"Nature"},{"key":"10.1038\/mt.2015.14_bib37","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1038\/sj.emboj.7600491","article-title":"Recognition and cleavage of primary microRNA precursors by the nuclear processing enzyme Drosha","volume":"24","author":"Zeng","year":"2005","journal-title":"EMBO J"},{"key":"10.1038\/mt.2015.14_bib38","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1038\/ng1650","article-title":"Second-generation shRNA libraries covering the mouse and human genomes","volume":"37","author":"Silva","year":"2005","journal-title":"Nat Genet"},{"key":"10.1038\/mt.2015.14_bib39","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1038\/ng1105-1163","article-title":"RNAi the natural way","volume":"37","author":"Cullen","year":"2005","journal-title":"Nat Genet"},{"key":"10.1038\/mt.2015.14_bib40","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/nbt.2612","article-title":"Image-based analysis of lipid nanoparticle-mediated siRNA delivery, intracellular trafficking and endosomal escape","volume":"31","author":"Gilleron","year":"2013","journal-title":"Nat Biotechnol"},{"key":"10.1038\/mt.2015.14_bib41","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/nbt.2614","article-title":"Efficiency of siRNA delivery by lipid nanoparticles is limited by endocytic recycling","volume":"31","author":"Sahay","year":"2013","journal-title":"Nat Biotechnol"}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001616301393?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001616301393?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,4,27]],"date-time":"2022-04-27T16:29:42Z","timestamp":1651076982000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001616301393"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6]]},"references-count":41,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["S1525001616301393"],"URL":"https:\/\/doi.org\/10.1038\/mt.2015.14","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2015,6]]}}}